In Vitro Diagnostics: Technologies and Global Markets
Report Scope:
The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines IVD market drivers, as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.
This study will provide information on these areas -
The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines IVD market drivers, as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.
This study will provide information on these areas -
- Structure and current market size of the IVD market as outlined with forecasts through 2025.
- Impact of chronic diseases, growing and aging populations.
- Current technology and product suppliers and key innovations.
- A look at the IVD industry and trends affecting the market.
- Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics).
- A global overview showing market data for North America, Europe, Asia-Pacific and Latin America, Africa and the Middle East (LAAM).
- Emerging opportunities and potential investment opportunity areas for IVD.
- Technology patent trends relating to IVD.
- Profiles for more than 20 companies in the industry with significant contributions and market shares.
- 47 data tables and 21 additional tables
- An overview of the global market for in vitro diagnostics (IVD) within the industry
- Analyses of global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth inhibiting areas that affect the global market
- Evaluation of market size and forecast, and technological advancements within the industry; and market share analysis of the global IVD market by application, segment and region
- A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
- Coverage of technologies such as IVD for neglected infectious diseases, chemistry-based portable analysis and discussion on advantages of microfluidic platform based POC tests
- Detailed description on COVID-9 pandemic, including symptoms, and progression; information on coronavirus disease 2019 testing basics and impact analysis of COVID-19 on the IVD market
- Comprehensive company profiles of major market players, including Abbott Diagnostics Inc., Beckman Coulter, Becton, Dickinson and Co., Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthcare and Thermo Fisher Scientific Inc.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Intended Readership
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Global Market Trends
CHAPTER 3 MARKET LANDSCAPE
COVID-19 Global Pandemic
Coronavirus Disease 2019 Testing Basics
Diagnostic Tests with Alternative Options
Molecular Diagnostic Tests
Increasing Access to Testing
Antigen Tests
Antibody (Serology) Tests
In Vitro Diagnostic Testing EUAs
Diagnostic Tests
Serology/Antibody Tests
Tests for the Management of COVID-19 Patients
Market Overview and Segmentation
Key Findings
Factors Influencing the Global IVD Market
Drivers
Challenges
Regulatory Landscape
IVD Regulations in North America
IVD Regulations in Europe
IVD Regulations in Asia-Pacific
IVD Regulations in LAAM (Latin America, Africa and Middle East)
CHAPTER 4 GLOBAL MARKET FOR IVD BY PRODUCT SEGMENT
Immunochemistry
POC IVD
Molecular Diagnostic Testing
Hematology
Clinical Microbiology
Tissue Diagnostic Testing
Trends in IVD Segments
Competitive Structure
Market Share Analysis
CHAPTER 5 GLOBAL MARKET FOR IMMUNOCHEMISTRY TESTING
Blood Gas, Electrolytes and Metabolites (BGEM)
Endocrine
Infectious Diseases
Cancer
Urinalysis
Diabetes
Cardiology
Blood Screening
Others
FDA Product Approvals in 2020
CHAPTER 6 GLOBAL MARKET FOR POC TESTING
Glucose Testing
BGEM
Cardiac Marker Testing
Infectious Disease Testing
Pregnancy and Fertility Testing
Drug and Alcohol Abuse Testing
Hematology and Hemostasis Testing
Cholesterol Testing
Urine Chemistry Testing
Tumor Marker Testing
Other Types of POC Testing
FDA Product Approvals in 2020
CHAPTER 7 GLOBAL MARKET FOR HEMATOLOGY TESTING
Routine Hematology Tests
Hemostasis
FDA Product Approvals in 2020
CHAPTER 8 GLOBAL MARKET FOR MOLECULAR DIAGNOSTIC TESTING
Infectious Diseases
Blood Screening
Oncology
Genetic Testing
Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases)
FDA Product Approvals in 2020
CHAPTER 9 GLOBAL MARKET FOR CLINICAL MICROBIOLOGY TESTING
Blood Culture
General Culture (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids)
Identification and Antibiotic Susceptibility Testing
FDA Product Approvals in 2020
CHAPTER 10 GLOBAL MARKET FOR TISSUE DIAGNOSTIC TESTING
Cancer Diagnosis
Tissue Typing
Pathogen Detection
CHAPTER 11 REGIONAL ANALYSIS
Introduction
North America
Europe
Asia-Pacific
LAAM
International Health Expenditure and Trends
North America
Europe
Western Europe
Central and Eastern Europe
Asia-Pacific
Latin America, Africa and Middle East (LAAM)
CHAPTER 12 MARKET TRENDS
End Users
Trends
Product Categories
Trends
Technology Trends
Industry Developments
Opportunities
IVD for Neglected Infectious Diseases
Portable Devices Compatible with Simple Detection Platforms
Chemistry-Based Portable Analyzers
Improved Sample Preservation Technologies
New Detection Technologies
Alternative Technologies to PCR
Key Biomarkers for Diseases of the Developing World
Microfluidic Platform-based POC Tests for Remote Settings
Combining Multiple Detection Technologies into a Single Instrument
CHAPTER 13 MERGERS AND ACQUISITIONS
CHAPTER 14 PATENT REVIEW
Coronavirus COVID-19 Diagnostics
CHAPTER 15 COMPANY PROFILES
ABBOTT DIAGNOSTICS INC.
ALERE SAN DIEGO INC.
ASCENSIA DIABETES CARE
BECKMAN COULTER (PART OF DANAHER)
BECTON DICKINSON AND CO.
BIOMERIEUX
BIO-RAD
DANAHER CORP.
ELITECH GROUP
HOLOGIC INC.
INSTRUMENTATION LABORATORY
KEMENTEC A/S
ORTHO CLINICAL DIAGNOSTICS
ROCHE DIAGNOSTICS CORP.
QUIDEL CORP.
SIEMENS HEALTHCARE DIAGNOSTICS INC.
SYSMEX
THERMO FISHER SCIENTIFIC INC.
TRANSASIA BIO-MEDICALS
WERFEN GROUP
CHAPTER 16 APPENDIX
LIST OF IVD MARKET PARTICIPANTS
LIST OF ACRONYMS
Study Goals and Objectives
Reasons for Doing This Study
Intended Readership
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Global Market Trends
CHAPTER 3 MARKET LANDSCAPE
COVID-19 Global Pandemic
Coronavirus Disease 2019 Testing Basics
Diagnostic Tests with Alternative Options
Molecular Diagnostic Tests
Increasing Access to Testing
Antigen Tests
Antibody (Serology) Tests
In Vitro Diagnostic Testing EUAs
Diagnostic Tests
Serology/Antibody Tests
Tests for the Management of COVID-19 Patients
Market Overview and Segmentation
Key Findings
Factors Influencing the Global IVD Market
Drivers
Challenges
Regulatory Landscape
IVD Regulations in North America
IVD Regulations in Europe
IVD Regulations in Asia-Pacific
IVD Regulations in LAAM (Latin America, Africa and Middle East)
CHAPTER 4 GLOBAL MARKET FOR IVD BY PRODUCT SEGMENT
Immunochemistry
POC IVD
Molecular Diagnostic Testing
Hematology
Clinical Microbiology
Tissue Diagnostic Testing
Trends in IVD Segments
Competitive Structure
Market Share Analysis
CHAPTER 5 GLOBAL MARKET FOR IMMUNOCHEMISTRY TESTING
Blood Gas, Electrolytes and Metabolites (BGEM)
Endocrine
Infectious Diseases
Cancer
Urinalysis
Diabetes
Cardiology
Blood Screening
Others
FDA Product Approvals in 2020
CHAPTER 6 GLOBAL MARKET FOR POC TESTING
Glucose Testing
BGEM
Cardiac Marker Testing
Infectious Disease Testing
Pregnancy and Fertility Testing
Drug and Alcohol Abuse Testing
Hematology and Hemostasis Testing
Cholesterol Testing
Urine Chemistry Testing
Tumor Marker Testing
Other Types of POC Testing
FDA Product Approvals in 2020
CHAPTER 7 GLOBAL MARKET FOR HEMATOLOGY TESTING
Routine Hematology Tests
Hemostasis
FDA Product Approvals in 2020
CHAPTER 8 GLOBAL MARKET FOR MOLECULAR DIAGNOSTIC TESTING
Infectious Diseases
Blood Screening
Oncology
Genetic Testing
Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases)
FDA Product Approvals in 2020
CHAPTER 9 GLOBAL MARKET FOR CLINICAL MICROBIOLOGY TESTING
Blood Culture
General Culture (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids)
Identification and Antibiotic Susceptibility Testing
FDA Product Approvals in 2020
CHAPTER 10 GLOBAL MARKET FOR TISSUE DIAGNOSTIC TESTING
Cancer Diagnosis
Tissue Typing
Pathogen Detection
CHAPTER 11 REGIONAL ANALYSIS
Introduction
North America
Europe
Asia-Pacific
LAAM
International Health Expenditure and Trends
North America
Europe
Western Europe
Central and Eastern Europe
Asia-Pacific
Latin America, Africa and Middle East (LAAM)
CHAPTER 12 MARKET TRENDS
End Users
Trends
Product Categories
Trends
Technology Trends
Industry Developments
Opportunities
IVD for Neglected Infectious Diseases
Portable Devices Compatible with Simple Detection Platforms
Chemistry-Based Portable Analyzers
Improved Sample Preservation Technologies
New Detection Technologies
Alternative Technologies to PCR
Key Biomarkers for Diseases of the Developing World
Microfluidic Platform-based POC Tests for Remote Settings
Combining Multiple Detection Technologies into a Single Instrument
CHAPTER 13 MERGERS AND ACQUISITIONS
CHAPTER 14 PATENT REVIEW
Coronavirus COVID-19 Diagnostics
CHAPTER 15 COMPANY PROFILES
ABBOTT DIAGNOSTICS INC.
ALERE SAN DIEGO INC.
ASCENSIA DIABETES CARE
BECKMAN COULTER (PART OF DANAHER)
BECTON DICKINSON AND CO.
BIOMERIEUX
BIO-RAD
DANAHER CORP.
ELITECH GROUP
HOLOGIC INC.
INSTRUMENTATION LABORATORY
KEMENTEC A/S
ORTHO CLINICAL DIAGNOSTICS
ROCHE DIAGNOSTICS CORP.
QUIDEL CORP.
SIEMENS HEALTHCARE DIAGNOSTICS INC.
SYSMEX
THERMO FISHER SCIENTIFIC INC.
TRANSASIA BIO-MEDICALS
WERFEN GROUP
CHAPTER 16 APPENDIX
LIST OF IVD MARKET PARTICIPANTS
LIST OF ACRONYMS
LIST OF TABLES
Summary Table: Global Market for In Vitro Diagnostics (IVD), by Region, Through 2025
Table 1: Total Cumulative Cases of COVID-19, by WHO Region/Country, as of 2/10/2021
Table 2: Different Types of Coronavirus Tests, 2020
Table 3: Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2 as of 2/1/2021
Table 4: Authorized Molecular-Based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2, as of 2/1/2021
Table 5: Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, as of 2/1/2021
Table 6: Individual EUAs for Serology Tests for SARS-CoV-2, as of 2/1/2021
Table 7: Individual EUAs for IVDs for the Management of COVID-19 Patients, as of 2/1/2021
Table 8: Types of Diagnostic Tests and How They are Regulated
Table 9: Changes in IVD Regulations in Asia-Pacific, 2020
Table 10: Global Market for IVD, by Segment, Through 2025
Table 11: Global Company Market Shares of IVD, 2020
Table 12: Global Market for Immunochemistry Testing, by Application, Through 2025
Table 13: Global Market for Immunochemistry Testing, by Region, Through 2025
Table 14: FDA Immunology Products Approved in 2020
Table 15: Global Market for POC Testing, by Application, Through 2025
Table 16: Global Market for POC Testing, by Region, Through 2025
Table 17: FDA POC Products Approved in 2020
Table 18: Global Market for Hematology Testing, by Application, Through 2025
Table 19: Global Market for Hematology Testing, by Region, Through 2025
Table 20: FDA Hematology Products Approved in 2020
Table 21: FDA Immunohematology Products Approved in 2020
Table 22: Global Market for Molecular Diagnostic Testing, by Application, Through 2025
Table 23: Global Market for Molecular Diagnostic Testing, by Region, Through 2025
Table 24: FDA-Approved Nucleic Acid-Based Human Genetic Tests, as of 2/1/2021
Table 25: FDA-Approved Nucleic Acid Based Microbial Tests, as of 2/1/2021
Table 26: List of Cleared or Approved Companion Diagnostic Devices,2/4/2021
Table 27: Global Market for Clinical Microbiology Testing, by Application, Through 2025
Table 28: Global Market for Clinical Microbiology Testing, by Region, Through 2025
Table 29: FDA Bacteriology Products Approved in 2020
Table 30: FDA Virology Products Approved in 2020
Table 31: Global Market for Tissue Diagnostic Testing, by Application, Through 2025
Table 32: Global Market for Tissue Diagnostic Testing, by Region, Through 2025
Table 33: Global COVID-19 Prevalence, by WHO Region/Country, 2/10/2021
Table 34: Global Market for IVD, by Region, Through 2025
Table 35: Global Market Shares of IVD, by Region, 2019-2025
Table 36: North American Market for IVD, by Segment, Through 2025
Table 37: North American Market for Immunochemistry Testing, by Segment, Through 2025
Table 38: North American Market for POC Testing, by Segment, Through 2025
Table 39: North American Market for Hematology Testing, by Segment, Through 2025
Table 40: North American Market for Molecular Diagnostic Testing, by Segment, Through 2025
Table 41: North American Market for Microbiology Diagnostic Testing, by Segment, Through 2025
Table 42: North American Market for Tissue Diagnostic Testing, by Segment, Through 2025
Table 43: European Market for IVD, by Segment, Through 2025
Table 44: European Market for Immunochemistry Testing, by Segment, Through 2025
Table 45: European Market for POC Testing, by Segment, Through 2025
Table 46: European Market for Hematology Testing, by Segment, Through 2025
Table 47: European Market for Molecular Diagnostic Testing, by Segment, Through 2025
Table 48: European Market for Microbiology Testing, by Segment, Through 2025
Table 49: European Market for Tissue Diagnostic Testing, by Segment, Through 2025
Table 50: Asia-Pacific Market Shares of IVD, by Country, 2020
Table 51: Asia-Pacific Market for IVD, by Segment, Through 2025
Table 52: Asia-Pacific Market for Immunochemistry Testing, by Segment, Through 2025
Table 53: Asia-Pacific Market for POC Testing, by Segment, Through 2025
Table 54: Asia-Pacific Market for Hematology Testing, by Segment, Through 2025
Table 55: Asia-Pacific Market for Molecular Diagnostic Testing, by Segment, Through 2025
Table 56: Asia-Pacific Market for Clinical Microbiology Testing, by Segment, Through 2025
Table 57: Asia-Pacific Market for Tissue Diagnostic Testing, by Segment, Through 2025
Table 58: LAAM Market for IVD, by Segment, Through 2025
Table 59: LAAM Market for Immunochemistry Testing, by Segment, Through 2025
Table 60: LAAM Market for POC Testing, by Segment, Through 2025
Table 61: LAAM Market for Hematology Testing, by Segment, Through 2025
Table 62: LAAM Market for Molecular Diagnostic Testing, by Segment, Through 2025
Table 63: LAAM Market for Clinical Microbiology Testing, by Segment, Through 2025
Table 64: LAAM Market for Tissue Diagnostic Testing, by Segment, Through 2025
Table 65: U.S. FDA Approvals of High-Complexity IVD Products, 2019-2020
Table 66: Diagnostics Manufacturer Mergers and Acquisitions, 2004-2020
Table 67: U.S. COVID-19-Related Patents, 2020
Summary Table: Global Market for In Vitro Diagnostics (IVD), by Region, Through 2025
Table 1: Total Cumulative Cases of COVID-19, by WHO Region/Country, as of 2/10/2021
Table 2: Different Types of Coronavirus Tests, 2020
Table 3: Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2 as of 2/1/2021
Table 4: Authorized Molecular-Based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2, as of 2/1/2021
Table 5: Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, as of 2/1/2021
Table 6: Individual EUAs for Serology Tests for SARS-CoV-2, as of 2/1/2021
Table 7: Individual EUAs for IVDs for the Management of COVID-19 Patients, as of 2/1/2021
Table 8: Types of Diagnostic Tests and How They are Regulated
Table 9: Changes in IVD Regulations in Asia-Pacific, 2020
Table 10: Global Market for IVD, by Segment, Through 2025
Table 11: Global Company Market Shares of IVD, 2020
Table 12: Global Market for Immunochemistry Testing, by Application, Through 2025
Table 13: Global Market for Immunochemistry Testing, by Region, Through 2025
Table 14: FDA Immunology Products Approved in 2020
Table 15: Global Market for POC Testing, by Application, Through 2025
Table 16: Global Market for POC Testing, by Region, Through 2025
Table 17: FDA POC Products Approved in 2020
Table 18: Global Market for Hematology Testing, by Application, Through 2025
Table 19: Global Market for Hematology Testing, by Region, Through 2025
Table 20: FDA Hematology Products Approved in 2020
Table 21: FDA Immunohematology Products Approved in 2020
Table 22: Global Market for Molecular Diagnostic Testing, by Application, Through 2025
Table 23: Global Market for Molecular Diagnostic Testing, by Region, Through 2025
Table 24: FDA-Approved Nucleic Acid-Based Human Genetic Tests, as of 2/1/2021
Table 25: FDA-Approved Nucleic Acid Based Microbial Tests, as of 2/1/2021
Table 26: List of Cleared or Approved Companion Diagnostic Devices,2/4/2021
Table 27: Global Market for Clinical Microbiology Testing, by Application, Through 2025
Table 28: Global Market for Clinical Microbiology Testing, by Region, Through 2025
Table 29: FDA Bacteriology Products Approved in 2020
Table 30: FDA Virology Products Approved in 2020
Table 31: Global Market for Tissue Diagnostic Testing, by Application, Through 2025
Table 32: Global Market for Tissue Diagnostic Testing, by Region, Through 2025
Table 33: Global COVID-19 Prevalence, by WHO Region/Country, 2/10/2021
Table 34: Global Market for IVD, by Region, Through 2025
Table 35: Global Market Shares of IVD, by Region, 2019-2025
Table 36: North American Market for IVD, by Segment, Through 2025
Table 37: North American Market for Immunochemistry Testing, by Segment, Through 2025
Table 38: North American Market for POC Testing, by Segment, Through 2025
Table 39: North American Market for Hematology Testing, by Segment, Through 2025
Table 40: North American Market for Molecular Diagnostic Testing, by Segment, Through 2025
Table 41: North American Market for Microbiology Diagnostic Testing, by Segment, Through 2025
Table 42: North American Market for Tissue Diagnostic Testing, by Segment, Through 2025
Table 43: European Market for IVD, by Segment, Through 2025
Table 44: European Market for Immunochemistry Testing, by Segment, Through 2025
Table 45: European Market for POC Testing, by Segment, Through 2025
Table 46: European Market for Hematology Testing, by Segment, Through 2025
Table 47: European Market for Molecular Diagnostic Testing, by Segment, Through 2025
Table 48: European Market for Microbiology Testing, by Segment, Through 2025
Table 49: European Market for Tissue Diagnostic Testing, by Segment, Through 2025
Table 50: Asia-Pacific Market Shares of IVD, by Country, 2020
Table 51: Asia-Pacific Market for IVD, by Segment, Through 2025
Table 52: Asia-Pacific Market for Immunochemistry Testing, by Segment, Through 2025
Table 53: Asia-Pacific Market for POC Testing, by Segment, Through 2025
Table 54: Asia-Pacific Market for Hematology Testing, by Segment, Through 2025
Table 55: Asia-Pacific Market for Molecular Diagnostic Testing, by Segment, Through 2025
Table 56: Asia-Pacific Market for Clinical Microbiology Testing, by Segment, Through 2025
Table 57: Asia-Pacific Market for Tissue Diagnostic Testing, by Segment, Through 2025
Table 58: LAAM Market for IVD, by Segment, Through 2025
Table 59: LAAM Market for Immunochemistry Testing, by Segment, Through 2025
Table 60: LAAM Market for POC Testing, by Segment, Through 2025
Table 61: LAAM Market for Hematology Testing, by Segment, Through 2025
Table 62: LAAM Market for Molecular Diagnostic Testing, by Segment, Through 2025
Table 63: LAAM Market for Clinical Microbiology Testing, by Segment, Through 2025
Table 64: LAAM Market for Tissue Diagnostic Testing, by Segment, Through 2025
Table 65: U.S. FDA Approvals of High-Complexity IVD Products, 2019-2020
Table 66: Diagnostics Manufacturer Mergers and Acquisitions, 2004-2020
Table 67: U.S. COVID-19-Related Patents, 2020
LIST OF FIGURES
Summary Figure: Global Market for In Vitro Diagnostics (IVD), by Region, 2019-2025
Figure 1: Global Market for IVD, by Segment, 2019-2025
Figure 2: Global Market Shares of IVD, by Segment, 2020
Figure 3: Global Market Shares of Immunochemistry Testing, by Application, 2020
Figure 4: Global Market for Immunochemistry Testing, by Region, 2019-2025
Figure 5: Global Market for POC Testing, by Application, 2019-2025
Figure 6: Global Market for POC Testing, by Region, 2019-2025
Figure 7: Global Market for Hematology Testing, by Application, 2019-2025
Figure 8: Global Market Shares of Hematology Testing, by Technique, 2020
Figure 9: Global Market Shares of Hematology Testing, by System, 2020
Figure 10: Global Market for Hematology Testing, by Region, 2019-2025
Figure 11: Global Market for Molecular Diagnostic Testing, by Application, 2019-2025
Figure 12: Global Market Shares of Molecular Diagnostic Testing, by Application, 2020
Figure 13: Global Market Shares of Molecular Diagnostic Testing, by Infectious Disease, 2020
Figure 14: Global Market for Molecular Diagnostic Testing, by Region, 2019-2025
Figure 15: Global Market for Clinical Microbiology Testing, by Application, 2019-2025
Figure 16: Global Market Shares of Clinical Microbiology Testing, by Application, 2020
Figure 17: Global Market for Clinical Microbiology Testing, by Region, 2019-2025
Figure 18: Global Market for Tissue Diagnostic Testing, by Application, 2019-2025
Figure 19: Global Market Shares of Tissue Diagnostic Testing, by Application, 2020
Figure 20: Global Market for Tissue Diagnostic Testing, by Region, 2019-2025
Figure 21: European Market Shares of IVD, by Country, 2020
Figure 22: Western European Market Shares of IVD, by Country, 2020
Figure 23: Central and Eastern European Market Shares of IVD, by Country, 2020
Figure 24: Latin American Market Shares of IVD, by Country, 2020
Figure 25: Middle East and African Market Shares of IVD, by Region, 2020
Figure 26: Global Market Shares of IVD, by End User, 2020
Figure 27: Global Market Shares of IVD, by Product Type, 2020
Summary Figure: Global Market for In Vitro Diagnostics (IVD), by Region, 2019-2025
Figure 1: Global Market for IVD, by Segment, 2019-2025
Figure 2: Global Market Shares of IVD, by Segment, 2020
Figure 3: Global Market Shares of Immunochemistry Testing, by Application, 2020
Figure 4: Global Market for Immunochemistry Testing, by Region, 2019-2025
Figure 5: Global Market for POC Testing, by Application, 2019-2025
Figure 6: Global Market for POC Testing, by Region, 2019-2025
Figure 7: Global Market for Hematology Testing, by Application, 2019-2025
Figure 8: Global Market Shares of Hematology Testing, by Technique, 2020
Figure 9: Global Market Shares of Hematology Testing, by System, 2020
Figure 10: Global Market for Hematology Testing, by Region, 2019-2025
Figure 11: Global Market for Molecular Diagnostic Testing, by Application, 2019-2025
Figure 12: Global Market Shares of Molecular Diagnostic Testing, by Application, 2020
Figure 13: Global Market Shares of Molecular Diagnostic Testing, by Infectious Disease, 2020
Figure 14: Global Market for Molecular Diagnostic Testing, by Region, 2019-2025
Figure 15: Global Market for Clinical Microbiology Testing, by Application, 2019-2025
Figure 16: Global Market Shares of Clinical Microbiology Testing, by Application, 2020
Figure 17: Global Market for Clinical Microbiology Testing, by Region, 2019-2025
Figure 18: Global Market for Tissue Diagnostic Testing, by Application, 2019-2025
Figure 19: Global Market Shares of Tissue Diagnostic Testing, by Application, 2020
Figure 20: Global Market for Tissue Diagnostic Testing, by Region, 2019-2025
Figure 21: European Market Shares of IVD, by Country, 2020
Figure 22: Western European Market Shares of IVD, by Country, 2020
Figure 23: Central and Eastern European Market Shares of IVD, by Country, 2020
Figure 24: Latin American Market Shares of IVD, by Country, 2020
Figure 25: Middle East and African Market Shares of IVD, by Region, 2020
Figure 26: Global Market Shares of IVD, by End User, 2020
Figure 27: Global Market Shares of IVD, by Product Type, 2020
